Subscribe to Newsletter

Laura Holtmann, Stephen Klutz, Martin Lobedann and Dr. Schembecker

Laura Holtmann started studying biochemical engineering at the TU Dortmund University in 2009 and completed her bachelor’s degree in 2013 and her master’s degree in 2014. She wrote her master thesis at INVITE GmbH in Leverkusen under the topic “Cost evaluation of monoclonal antibody production processes in different operation modes”. Since 2015, she works as a research associate at INVITE GmbH where she focuses on viral clearance for continuous, biopharmaceutical processes.


Stephan Klutz completed his diploma degree in mechanical engineering at RWTH Aachen University in 2011. From 2011 to 2015 he worked as a research associate at INVITE GmbH where he focused on continuous processing of monoclonal antibodies. In parallel he completed his master´s degree in economics at RWTH Aachen University in 2015. Since 2016, he works in the field of project management at Bayer.


Martin Lobedann is a biochemical engineer and a PhD in Biotech-Engineering. He joint Bayer in 2010 before having an assignment at the Bayer daughter company Invite GmbH in 2011, heading the group Biotechnology. He is working in the field of biopharma covering conceptual design, engineering, process control and process analytical technology.


Dr. Schembecker received his diploma as well as his Ph.D. in Chemical Engineering from TU Dortmund University in Germany. He is co-founder of the consultancy firms Process Design Center, inosim Consulting and b-value. In September 2005 he was appointed Professor for Plant and Process Design at the Department of Biochemical and Chemical Engineering of TU Dortmund University. His research interests focus on the conceptual design and simulation of (bio)chemical processes with special interest in innovative downstream processes and on module based plant design.

Content by Laura Holtmann, Stephen Klutz, Martin Lobedann and Dr. Schembecker:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine